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Abstract: The aim of this study was to examine the quality of data collection by studying the validity of collected data. 
Data were extracted from the clinic charts of two anonymous outpatients by 38 data collectors. A standard for the data to 
be collected was determined (168 items). The validity was measured by comparing the collected items with the standard; 
in this way, the percentages of the collected items that were ‘correct’ could be calculated. The percentage ‘correct’ was 
higher for clinic chart 1 (mean: 83% correct, SD 7%) than for clinic chart 2 (mean: 78% correct, SD 8%). All categories 
contained incorrectly collected data. These data were divided into missing data, incorrect start-stop dates, and surplus 
collected data. Almost all start-stop dates would change into ‘correct’ if ‘monthyear’ was considered correct (instead of 
the standard ‘daymonthyear’). Not all data collectors used specific protocols, and sources other than the written comments 
were not always checked. This study shows that a high proportion of data was correctly collected. However, the collection 
of start-stop dates was not optimal, and the collected data included surplus and missing data. Data collectors should be 
more knowledgeable about HIV disease and trained in the use of difficult protocols, so that they can better recognize what 
data to collect and how it should be collected. Among physicians, there should be more agreement about what information 
to record in the charts, to facilitate data extraction for data collectors. 
Keywords: Database, manual data entry, quality of data collection, HIV/AIDS. 
INTRODUCTION 
 From a public health perspective, it is important to 
monitor the outcomes of HIV-infected individuals on a 
national level [1]. In the Netherlands, the HIV Monitoring 
Foundation (HMF) performs the prospective collection of 
data on HIV-infected persons, which is part of routine health 
care for these patients. The mission of the HMF is to expand 
the knowledge and understanding of the epidemiology and 
course of both treated and untreated HIV infection. To 
achieve this mission, the HMF engages in activities such as 
collecting and processing data and making them available to 
researchers. By 1 June 2009, the HMF had collected and 
stored data in the ATHENA (AIDS Therapy Evaluation in 
the Netherlands) database from 16,129 HIV-infected persons 
registered in one of the 25 HIV treatment centres in the 
Netherlands. In the treatment centres, data collectors obtain 
data directly from the patients’ medical files. Data collectors 
are divided into core function data collectors and additional 
job data collectors (HIV consultants and medical 
secretaries). Data collectors (DCs), supervised by treating 
physicians, enter the data online into the national ATHENA 
database, using specific protocols to standardize the data 
collection and to minimize errors [2, 3]. This database was 
developed in Oracle Clinical
®
 (OC), a system specifically  
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designed for the management of clinical trial data that 
complies with the guidelines of the International Conference 
on Harmonisation (Good Clinical Practice) and the U.S. 
Food and Drug Administration. The OC database provides 
cross-checking options and discrepancy checks, which 
increases the efficiency and accuracy of data entry [2, 4-7]. 
Data monitors (DMs) supervise the quality of the data by 
checking their accuracy and completeness. The data are then 
compared to those in the source documents, such as medical 
files and electronic laboratory results. In addition, the DMs 
check for the correct use of specific protocols and privacy 
regulations, and they train the DCs in complete and accurate 
collection. Regular feedback and training maximises the 
reliability of the data [2, 8]. Controlling the quality of data 
obtained from patients is crucial for all clinical research, and 
source data verification (SDV) is the preferred approach [2-
4, 8, 9]. However, given the large population size, 100% 
SDV is not feasible. Therefore, the HMF has implemented 
customized procedures for improving the quality of data by 
restricting SDV to all end-points essential for key data 
analysis, such as death. In this way, SDV can be used even 
for data sets that include large numbers of patients. In 
addition, HMF develops strategies to replace the manual 
collection of laboratory results by ‘direct uploading’ from 
hospital laboratory databases (‘lablink’) [10], since direct 
uploading of the laboratory results improves the quality of 
data [10]. In this study, we determined whether the DCs 
collected the information that should be collected. We 
studied the validity of the collected data in all other 
categories (‘adverse events’, ‘AIDS-defining events (CDC)’, 
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‘Antiretroviral Therapy (ART) ‘, ‘co-medication’ and ‘once-
only data’) to provide further insight into the optimisation of 
procedures for manual data entry [10]. 
METHODS 
Design 
 The outpatient clinic charts from two anonymous patients 
were selected. The first clinic chart consisted of data from 
the first visit to the outpatient clinic of an HIV treatment 
centre (once-only data) and three follow-up visits 
(longitudinal data). The second clinic chart consisted of nine 
follow-up visits. A pilot study was performed by the four 
DMs, who collected the data from the two charts. The 
purpose of that study was to examine the representativeness 
of the charts and to determine the standard for the present 
study. On the basis of the DMs' experience, all four 
considered the charts to be representative. Because the DMs 
normally check the data's accuracy and completeness, and 
check for the correct use of specific protocols, they were able 
to determine the standard for the collected information. The 
specific protocols were used to determine this standard. 
Study Population 
 Of the 42 DCs eligible to participate in this study, 38 
took part; four DCs were not able to participate (another job 
(2), sick leave (1), too busy (1)). All 38 DCs collected the 
data from the first chart; 36 DCs collected the data from the 
second chart. Two DCs could not collect the data from the 
second chart (time shortage at last working day and just 
started as a DC). 
Data Collection 
 A letter was sent to all DCs inviting their participation, 
and a presentation was given regarding the research. To 
guarantee the anonymity of the DCs, we used new log in 
codes for the OC database, and the data were reversibly 
anonymised. From April to October 2007, the DCs 
participated with the Oracle Clinical
®
 database in their own 
workplace. After the data was collected from each chart, the 
DCs were interviewed by a researcher using a standardized 
questionnaire. The purpose of this questionnaire was to 
gather information about the use of protocols and the 
characteristics of the DCs (main topics of these questions 
were: function (HIV consultants, medical secretaries, core 
function DCs), education (university (of applied sciences) 
and university-preparatory school, post-secondary and 
vocational education), full-time equivalent (1-16 hours a 
week, 17-40 hours a week), duration of the data collection 
(hours), year of employment), as well as to determine the 
representativeness of the charts as ascertained by the DCs 
(lay-out of the charts, handwriting, abbreviations, 
availability of information). 
Statistical Analysis 
 The items collected by the DCs were compared to the 
standard, which consisted of 168 items, and they were coded 
as ‘correct’ or ‘incorrect’. The percentages of correct and 
incorrectly collected data of the individual charts (overall), 
both charts together (overall), and of all categories (‘adverse 
events’, ‘CDC events’, ‘ART’, ‘co-medication’ and ‘once-
only data’) were calculated (by data collector). The statistical 
tests used for the normally distributed variables were 
Student’s t-test and univariate linear regression analysis; 
those used for the non-normally distributed variables were 
Wilcoxon rank sum test, Spearman’s rank correlation 
coefficient, and Fisher’s exact test. 
 All statistical analyses were performed with SAS
®
 
version 9.1 (Statistical Analysis Software). 
RESULTS 
Representativity Chart 1 (N=38) 
 No difficulties in collecting data were mentioned by 86% 
of the DCs. These DCs found chart 1 no different from 
charts they usually handle, although the type of information 
in this chart occurs less frequently during usual data 
collection. Of all the DCs, 84% evaluated the lay-out of the 
chart as clearer than or similar to the charts they usually 
handle. The handwriting was assessed as clearer or similar 
by 92% of the DCs; 92% also found the abbreviations clearer 
or similar, and 63% usually had equal or less information 
available. 
Representativity Chart 2 (N=36): 
 No difficulties in collecting data were mentioned by 77% 
of the DCs. These DCs found chart 2, in general, not 
different from usual, except there were more switches of 
treatment regimen during data collection. Of all the DCs, 
92% evaluated the lay-out of the chart as clearer than or 
similar to the charts they normally handle. The handwriting 
was assessed as clearer or similar by 86% of the DCs, 88% 
found the abbreviations clearer or similar, and 72% usually 
had equal or less information available. 
Percentages ‘Correct’ Chart 1: 
 The collected items from chart 1 were grouped into six 
categories (Table 1a); ‘data collection first visit’ (29% of all 
items to collect from chart 1), ‘co-medication’ (19%), ‘ART’ 
(18%), ‘clinical visits’ (18%), ‘adverse events’ (8%) and 
‘CDC events’ (8%). Overall, the mean score of chart 1 was 
83% ‘correct’ (SD 7%). The categories ‘adverse events’ and 
‘CDC events’ showed the lowest mean percentages ‘correct’ 
(respectively, mean 56%, SD 31% and mean 60%, SD 13%). 
The categories of ‘clinical visits’ and ‘ART’ had the highest 
mean percentages ‘correct’ (respectively, mean 96%, SD 7% 
and mean 92%, SD 11%). There was no significant 
difference in the percentages ‘correct’ when the protocols 
were used and when they were not used. 
Percentages ‘Correct’ Chart 2 
 The collected items from chart 2 were grouped into five 
categories (Table 1b); ‘ART’ (58% of all items to collect 
from chart 2), ‘clinical visits’ (28%), ‘adverse events’ (9%), 
‘co-medication’ (4%) and’ CDC events’ (1%). Overall, the 
mean score of chart 2 was 78% ‘correct’ (SD 8%). The 
category of ‘co-medication’ showed the lowest mean 
percentage ‘correct’ (mean 65%, SD 18%). The category of 
‘clinical visits’ had the highest mean percentage ‘correct’ 
(mean 91%, SD 8%). There was no significant difference in 
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the percentages ‘correct’ when the protocols were used and 
when they were not used. 
Characteristics of the Charts and Percentages ‘Correct’ 
 Tables 2a and 2b show the results by characteristics of 
the collected items in charts 1 and 2. The tables consist of 
missing items, correct start and stop dates (according to the 
standard), and surplus collected items. The start and stop 
dates are divided into ‘ddmmyy’ (standard in most cases), 
only ‘mmyy’, and only ‘yy’. When we looked only at 
‘mmyy’ and ‘yy’, the percentages ‘correct’ increased 
substantially. The surplus collected data were partially false  
 
and partially unnecessarily collected (data not shown). All 
second stop reasons for ‘ART’ (Table 2b) showed low 
percentages ‘correct’. 
Correlation Between Variables 
 The correlation of seven variables of chart 1 and chart 2 
was assessed (duration of data collection, ‘adverse events’, 
‘ART’, ‘co-medication’, ‘ART’ with ‘co-medication’, durat-
ion with experience (by chart)). Of these variables, only the 
duration of the data collection from chart 1 correlated with 
the duration of the data collection from chart 2 (Spearman 
R= 0.6820, P<0.001). 
Table 1a. Percentages ‘Correct’ Collected Categories, Chart 1 
  
Chart 1 N=38 data collectors Percentages ‘Correct’  
  Mean SD*** Minimum Maximum Using Protocol 
Mean (N) 
Not Using 
Protocol Mean (N) 
P-Value 
Overall:        
correct chart 1  (%) 83 7 65 94 85  (N=16)   82 (N=22) 0.16 * 
Categories:        
correct data, only collected at first visit 
(%) 
84 8 68 100 85  a (N=16)   84  a  (N=22)   0.67 ** 
correct AIDS-defining events (%) 60 13 33 80 60  a (N=34)   65  a  (N=4)  0.46 ** 
correct adverse events (%) 56 31 0 100 57  a (N=22)  55  a  (N=16)  0.93 ** 
correct Antiretroviral Therapy (%) 92 11 63 100 86  a (N=26)    88  a  (N=12)   0.31 ** 
correct co medication (%) 84 14 50 100 85  a (N=36) 66  a  (N=2)   0.09 ** 
correct visits (%) **** 96 7 75 100 - - - 
*Student’s t-test. 
**Wilcoxon rank sum test. 
***Standard deviation. 
****No protocol. 
aThe ‘mean’ is given instead of the ‘mean rank score’ to better understand the differences. 
 
Table 1b. Percentages ‘Correct’ Collected Categories, Chart 2 
 
Chart 2 N=36 Data Collectors Percentages ‘Correct’  
  Mean SD*** Minimum Maximum Using Protocol 
Mean (N) 
Not Using Protocol 
Mean (N) 
P-Value 
Overall        
 correct chart 2 (%) 78 8 58 91  81 (N=6)   77  (N=30)   0.40 * 
Categories:        
 correct AIDS-defining  events (%) **** 100 0 100 100 - - - 
 correct adverse events (%) 75 20 14 100 74 a  (N=16)  75 a  (N=20)  0.90 ** 
 correct Antiretroviral Therapy (%) 72 11 47 92 73 a  (N=29)  69 a  (N=7)  0.31 ** 
 correct co medication (%) 65 18 33 100 67 a  (N=30)   57 a  (N=6)   0.23 ** 
 correct visits (%) ***** 91 8 76 100 - - - 
*Student’s t-test. 
**Wilcoxon rank sum test. 
***Standard deviation. 
****No AIDS-defining events had to be collected. 
*****No protocol. 
aThe ‘mean’ is given instead of the ‘mean rank score’ to better understand the differences. 
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Requests for Supplementary Data 
 DCs had the opportunity to request supplementary data 
from the treating physician (by means of a handwritten note). 
To examine the association between ‘a request’ and ‘no 
request’ and the percentage ‘correct’ for this question, 
Fisher’s exact test was used. The Fisher’s exact test showed 
only one association, and that was between the question ‘Is 
the patient still using omeprazol?’ and the percentage 
‘correct’ of stop date omeprazol (P=0.0341). DCs who asked 
this question collected the stop date incorrectly. 
Characteristics of DCs 
 Table 3 shows the relationship between characteristics of 
the DCs (function, education, full-time equivalent, duration 
of data collection, year of employment, employment 
experience) and percentage ‘correct’ for chart 1. In the 
univariate linear regression analysis, only function is 
associated with the percentage ‘correct’ for chart 1 and for 
combined charts 1 and 2 (data not shown). HIV consultants 
had significant lower overall score for percentage ‘correct’ 
than the core function DCs had for chart 1 (80% vs 86%) and 
for combined charts 1 and 2 (79% vs 85%). 
HIV Consultants vs Core Function DCs 
 Since function was associated with percentage ‘correct’ 
for chart 1 and for combined charts 1 and 2, the Wilcoxon 
rank-sum test was used to compare the percentages ‘correct’ 
for HIV consultants with those of core function DCs (Table 
4). A significant difference in percentages ‘correct’ was seen 
for ‘adverse events’, ‘ART’ and ‘data collected at first visit 
only’. The HIV consultants had lower percentages ‘correct’ 
for those categories than core function DCs had (respectively 
57% vs 74%, 70% vs 80%, 81% vs 87%). 
 
DISCUSSION 
 The aim of this study was to examine the quality of data 
collection of HIV infected patients by studying the validity 
of collected data. Data were extracted from the clinic charts 
of two anonymous outpatients by data collectors. 
 Policy, guidelines, and recommendations for further 
research are based on the results of research that depend on 
the quality of the collected data [4, 8]. Improving the validity 
of data is essential to ensure valid results [4]. In this study, 
the validity was measured by comparing the collected items 
with the standard, so that the percentages ‘correct’ of the 
collected items could be calculated. 
 To collect accurate data, it is necessary that the charts 
contain complete data. If information is missing in the 
charts, data collection will be incomplete. In this study, all 
collected data was compared to the standard. Therefore, if 
the charts consisted of incomplete data (care was provided 
but not recorded), the standard consisted of incomplete data 
as well. Incomplete information in the charts does not 
explain missing and incorrectly collected data in this study. 
 A chart consists of medical letters, written comments, 
diagnostic information, and laboratory results. All of these 
sources can contain information that has to be collected. The 
written comments are the guideline for collection, but all 
other sources need to be checked for additional information. 
Chart 1 contained more data sources than chart 2, which 
mainly pertained to ‘the data collected at the first visit only’ 
(‘once-only data’), ‘adverse events’, and ‘CDC events’. The 
sources for ‘once-only data’ were medical letters, written 
comments, and diagnostic information. The sources for 
events (‘adverse events’ and ‘CDC events’) were mainly 
diagnostic information and medical letters. If the  
 
Table 2a. Most Relevant Results of the Data Collection, Chart 1, N=38 Data Collectors 
 
Categories Characteristics of 
the Chart 
Missing 
Items 
Correct Start Date  
(If Collected) 
ddmmyy
1
   mmyy
2
      yy
3
 
Missing  
Stop 
Date 
Correct Stop Date  
(if Collected) 
ddmmyy
1    
mmyy
2
  yy
3
 
Surplus  
Collected  Data 
Demography 
Transmission 
History of HIV infection 
Data collection 
Male  (%) 
Heterosexual (%) 
HIV-1 infection (%) 
21-07-2004  (%) 
0 
0 
0 
0 
- 
- 
34.2 
50.0    
- 
- 
94.7 
55.2 
- 
- 
100  
100   
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
15 HIV-2 dates 
- 
AIDS-defining events Toxoplamosis   (%) 0 15.7   100 100   52.6  27.7 50 94.4 7 AIDS-defining events 
Adverse events Hospitalization  (%) 18.4  29.2   97.5 100    0 75.6 75.6 100 27 adverse events 
Antiretroviral Therapy Combivir  (%) 
Kaletra  (%) 
2.5 
0 
86.4  
86.8  
100 
100 
100    
100    
- 
- 
- 
- 
- 
- 
- 
- 
1 ART 
Co-medication Cotrim  (%) 
Folinezuur  (%) 
Pyrimethamine  (%) 
Sulfadiazine  (%) 
2.5 
0 
0 
0 
54.0  
71.0  
63.1  
86.8  
94.5 
94.7 
94.7 
100 
100    
100    
100    
100    
5.4 
- 
- 
13.1 
91.8 
- 
- 
90.9 
91.8 
- 
- 
90.9 
91.8 
- 
- 
100 
11 co medications 
Visits 4 visits  (%) 3.2  98.6  100 100  - - - 2 visits 
1Daymonthyear, 2Monthyear, 3Year. 
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characteristics of the patient contained ‘once-only data’ 
and/or events, sources other than written comments had to be 
checked. The sources that deviated from the written 
comments in chart 1 then might be an explanation for 
missing and incorrectly collected data. 
 Many start-stop dates would have been classified as 
‘correct’ if ‘mmyy’ had been considered correct, instead of 
‘ddmmyy’. However, specific start-stop dates are essential 
for all researchers who study, for example, short-term effects 
of ART, toxicity reactions, ART switch/stop reasons, and 
clinical progression. Therefore, start-stop dates should be 
correctly collected as ‘ddmmyy’, when information about 
dates is available. 
 The HIV consultants achieved a significant lower correct 
score than core function DCs in the specific categories of 
‘adverse events’, ‘ART’ and ‘once-only data’. An 
explanation for the lower correct score is that the HIV 
consultants used the specific protocols less frequently than 
did the core function DCs (data not shown). Another 
explanation for the lower correct score is that the consultants 
usually treat HIV patients themselves and know (mostly) 
their state of health from memory. In this study, they had to 
collect data from unknown patients. Therefore, this could 
have been a disadvantage. However, to reduce errors, DCs 
should always use the clinical charts, not memory, as the 
source for data collection. 
 All collected categories contained incorrect data. The 
incorrect data were divided into missing data, incorrect start-
stop dates, and surplus collected data. The surplus collected 
data consisted of partially false and partially unnecessary 
information (data not shown). To reduce data errors, DCs 
should use protocols [2, 11, 12]. Protocols should be easy to 
follow, with clear descriptions of what data to collect [3, 11]. 
During the data collection in this study, not all DCs used 
specific protocols. Contrary to our expectations, we found 
that, although start-stop dates of all medication, ‘adverse 
Table 2b. Most Relevant Results of the Data Collection, Chart 2, N=36 Data Collectors 
 
Categories Characteristics 
of the Chart 
Missing 
Items 
Correct Start Date   
(If Collected) 
ddmmyy
1 
  mmyy
2 
  yy
3 
Missing 
Stop 
Date 
Correct Stop Date 
 (If Collected) 
ddmmyy
1   
mmyy
2
     yy
3
 
Correct  
First  
Stop 
Reason 
Therapy
4 
Correct  
Second 
Stop 
Reason 
Therapy
4 
Surplus  
Collected  
Data 
AIDS-
defining 
events 
No event - - - - - - - - - - - 
Adverse 
events 
Groggy/ dizzy (%) 
Diarrhoea  (%) 
Lipodystrophy  
(%) 
2.7  
5.5 
0  
51.1 
41.1 
- 
60.4 
73.5 
- 
86.0 
94.1 
- 
- 
2.9 
- 
72.0 
72.7 
- 
72.0 
72.7 
- 
100 
96.9 
- 
- 
- 
- 
- 
- 
- 
12 adverse events 
Antiretro-
viral 
Therapy 
Start: 
Efavirenz  (%) 
DDI  (%) 
TDF  (%) 
Kaletra  (%) 
Emtricitabine  (%) 
DDI (%) 
Lamivudine  (%) 5 
DDI  (%) 
Abacavir  (%) 
 
Stop: 
Lamivudine  (%) 
Stavudine  (%) 
Kaletra  (%) 
Efavirenz  (%) 
DDI  (%) 
Emtricitabine  (%) 
Lamivudine  (%) 5 
DDI  (%) 
TDF  (%) 
 
0 
0 
0 
0 
0 
2.7 
69.5  
27.8  
2.7 
 
 
0 
0 
0 
0 
0 
0 
69.5  
27.8  
5.5  
 
69.4 
69.4 
69.4 
80.5 
77.7 
77.1 
- 
84.6 
80.0 
 
 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 
100 
100 
100 
100 
100 
100 
45.4 
100 
100 
 
 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 
100 
100 
100 
100 
100 
100 
100 
100 
100 
 
 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 
 
0 
0 
0 
0 
0 
0 
0 
0 
0 
 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 
 
77.7 
77.7 
77.7 
97.2 
100 
- 
- 
100 
100 
 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 
 
97.2 
97.2 
97.2 
100 
100 
13.8 
9.0 
100 
100 
 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 
 
100 
100 
100 
100 
100 
100 
100 
100 
100 
 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 
 
83.3 
91.7 
91.7 
94.4 
83.3 
86.1 
63.6 
46.1 
27.7 
 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 
 
27.7 
27.7 
27.7 
30.5 
- 
13.8  
27.2 
- 
- 
1 ART 
Co-
medication 
Omeprazol  (%) 0 33.3 52.7 91.6 52.7 64.7 64.7 100 - - 4 co medications 
Visits 9 visits  (%) 7.0   90.8 100 100 - - - - - - 24 visits 
1Daymonthyear, 2Monthyear, 3Year, 4Antiretroviral Therapy, 5The standard was ‘mmyy’. 
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events’, and ‘CDC events’ were defined in specific 
protocols, there was no significant difference in the 
percentages ‘correct’ when the protocols were used and 
when they were not used. A plausible explanation is that the 
protocols of the HMF were too difficult to follow, and 
therefore, errors were made. The protocols are difficult 
because of the complexity of the HIV disease and because 
the content of charts varies amongst physicians. The 
protocols of the HMF try to include all variations in chart 
content to help the DCs with data extraction. 
 There were several limitations to this study. First, the 
small sample size resulted in a lack of power; because of 
this, we found fewer predictors of data quality than expected. 
Nevertheless, the sample size was representative of the 
population of interest; nearly all data collectors were 
included. There were four non-responders for chart 1 and six 
non-responders for chart 2. If all data collectors had been 
included, this would not have changed the proportion of HIV 
consultants vs that of core function data collectors. 
Multivariate regression analyses could not be performed 
because of the small sample size, and thus we could not 
correct for confounding factors. Second, multiple analyses 
were performed in the study, so we expected no confounding 
factors, but unmeasured confounding will always exist. 
Because of multiple testing, there is chance of a type 1 error. 
However, we do not think the significant lower correct score 
of consultants was a result of a type 1 error. These data 
errors can be explained by the consultants' collecting data 
from patients they did not know and by the less frequent use 
of specific protocols. 
 This study shows a high proportion of correctly collected 
data. However, the collection of start-stop dates was not 
optimal, and the collected data consisted of surplus as well 
as missing data. The explanation for this is that not all 
collectors used the specific protocols, although there was no 
significant difference in the percentages ‘correct’ when the 
protocols were used and when they were not used. 
Furthermore, DCs probably did not always check sources 
Table 3. Univariate linear Regression Analysis on Percentage ‘Correct’ for Clinic Chart 1, N=38 Data Collectors 
 
Independent Variable Characteristics of the DCs Sample 
Size 
B 
(% Correct) 
SE  P-Value
a 
Overall 
P- Value 
Function HIV consultants  
Medical secretaries 
Core function (constant) 
15 
4 
19 
80 
84 
86 
2.2 
3.5 
1.5 
0.015  
0.62  
  
0.049 
Education 
 
University (of Applied Sciences), University- preparatory School 
 
Post-secondary and Vocational education (constant) 
18 
 
20 
82 
 
84 
2.2 
 
1.5 
0.34 
 
 
Full-time equivalent 1-16 hours a week 
17-40 hours a week (constant) 
21 
17 
82 
85 
2.2 
1.6 
0.12 
  
 
Duration of the data collection Hours 
Constant 
38 0.01448 
0.81603 
0.02442 
0.03274 
0.56  
Year of employment  After 2003 
Before 2003  (constant) 
22 
16 
83 
85 
2.3 
1.7 
0.39 
  
 
Year of employment After 2005 
Before 2005 (constant) 
13 
25 
84 
83 
2.4 
1.4 
0.94 
  
 
Employment experience  Years 
Constant 
38 0.03506 
0.82268 
0.03121 
0.01514 
0.27 
  
 
a P values <0.05 were considered significant and are represented in bold.    
 
Table 4. HIV Consultants vs Core Function Data Collectors 
 
Variable HIV Consultant  (N=14) Core Function  (N=18) P-Value 
a b
 
% Correct Mean 
c 
Mean 
c 
 
Adverse events chart 1 + chart 2 57 74 0.013 
Antiretroviral Therapy chart 1 + chart 2 70 80 0.006 
Data collected at first visit only, chart 1 81 87 0.049  
Co-medication chart 1 + chart 2 79 81 0.64 
AIDS-defining events chart 1 + chart 2 66 67 0.75 
aP-values <0.05 were considered significant and represented in bold. 
bWilcoxon rank sum test. 
cThe ‘mean’ is given instead of the ‘mean rank score’ to better understand the differences. 
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other than the written comments in the charts, which might 
have resulted in a higher proportion of incorrectly collected 
data. The HIV consultants scored lower in percentages 
‘correct’ than the core function data collectors, possibly 
because they were not familiar with these patients and used 
the specific protocols less frequently than the core function 
data collectors. The following recommendations make it 
possible for the HMF to increase the validity of the data. 
First, the specific protocols should be easy to follow, with 
clear descriptions [3, 11], but because of the complexity of 
the HIV disease and the variation in the content of the charts, 
the protocols remain difficult. Therefore, DCs should 
increase their knowledge of HIV disease, so they can better 
recognize what data to collect. DCs should also be trained in 
the use of difficult protocols to improve their ability to 
collect data. In addition, there should be more agreement 
among physicians about what information to record in the 
charts to facilitate data extraction for the DCs [13]. Finally, 
all DCs need to be trained to check sources other than 
written comments, especially if the characteristics of the 
patient contain ‘data collected at first visit only’ and/or 
events (‘adverse events’ and ‘CDC events’). In particular, it 
must be recognized that recall bias might result from the 
HIV consultants collecting data partially from memory 
(knowing their own patients’ state of health). Ideally, 
collected data should be based strictly on information in the 
clinical chart. 
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CDC = U.S. Centers for Disease Control and  
   Prevention 
DC = Data collectors 
DM = Data monitors 
HIV = Human Immunodeficiency Virus 
HMF = HIV Monitoring Foundation 
OC = Oracle Clinical 
®
 
SAS
®
 = Statistical Analysis Software 
SDV = Source Data Verification 
REFERENCES 
[1] The UK Collaborative HIV Cohort Steering Committee. The 
creation of a large UK-based multicentre cohort of HIV-infected 
individuals: The UK Collaborative HIV Cohort (UK CHIC) Study. 
HIV Med 2004; 5: 115-24. 
[2] Schneider JK, Deenan A. Reducing quantitative data errors: tips for 
clinical researchers. Appl Nurs Res 2004; 17: 125-29. 
[3] Favalli G, Vermorken JB, Vantongelen K, Renard J, Van Oosterom 
AT, Pecorelli S. Quality control in multicentric clinical trials. An 
experience of the EORTC Gynecological Cancer Cooperative 
Group. Eur J Cancer 2000; 36: 1125-33. 
[4] Cassidy LD, Marsh GM, Holleran MK, Ruhl LS. Methodology to 
improve data quality from chart review in the managed care setting. 
Am J Manag Care 2002; 8: 787-93. 
[5] Mullooly JP. The effects of data entry error: an analysis of partial 
verification. Comput Biomed Res 1990; 23: 259-67. 
[6] McGinniss MJ, Chen R, Pratt VM, et al. Development of a web-
based query tool for quality assurance of clinical molecular genetic 
test results. J Mol Diagn 2007; 9: 95-98. 
[7] Black N. Using clinical databases in practice. BMJ 2003; 4: 326-
29. 
[8] Freeman JA, Hobart JC, Playford ED, Undy B, Thompson AJ. 
Evaluating neurorehabilitation: lessons from routine data 
collection. J Neurol Neurosurg Psychiatry 2005; 76: 723-28. 
[9] Allison JJ, Wall TC, Spettell CM, et al. The art and science of chart 
review. Jt Comm J Qual Improv 2000; 26: 115-36. 
[10] HIV Monitoring Foundation. Monitoring of Human 
Immunodeficiency Virus (HIV) Infection in the Netherlands. 
Report. Amsterdam: Stichting HIV Monitoring/HIV Monitoring 
Foundation 2005. 
[11] Moody LE, McMillan S. Maintaining data integrity in randomized 
clinical trials. Nurs Res 2002; 51: 129-33. 
[12] Baigent C, Harrell FE, Buyse M, Emberson JR, Altman DG. 
Ensuring trial validity by data quality assurance and diversification 
of monitoring methods. Clin Trials 2008; 5: 49-55. 
[13] Luck J, Peabody JW, Dresselhaus TR, Lee M, Glassman P. How 
well does chart abstraction measure quality? A prospective 
comparison of standardized patients with the medical record. Am J 
Med 2000; 108: 642-49. 
 
 
Received: August 14, 2009 Revised: November 26, 2009 Accepted: December 15, 2009 
 
© Hillebregt et al.; Licensee Bentham Open. 
 
This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http: //creativecommons.org/licenses/by-nc/ 
3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. 
 
